Detalhe da pesquisa
1.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Diabetes Obes Metab
; 25(7): 1890-1899, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906837
2.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111434
3.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666013
4.
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
Diabetes Obes Metab
; 24(9): 1734-1740, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546275
5.
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER.
BMC Endocr Disord
; 22(1): 111, 2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35473607
6.
Pragmatic Clinic-Based Investigation of Glycemic Variability in Patients With Type 1 Diabetes in Routine Clinical Practice and Its Association With Cardiovascular Autonomic Neuropathy: A Pilot Study.
Endocr Pract
; 28(5): 465-471, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158057
7.
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Diabetes Obes Metab
; 23(8): 1823-1833, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852202
8.
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(8): 1956-1960, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852196
9.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845558
10.
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 22(1): 66-78, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468637
11.
Genomic ancestry and glycemic control in adolescents with type 1 diabetes: A multicenter study in Brazil.
Pediatr Diabetes
; 21(5): 727-734, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335987
12.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2474-2485, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297947
13.
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Cardiovasc Diabetol
; 17(1): 150, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486889
14.
Sensibility and specificity of laser speckle contrast imaging according to Endo-PAT index in type 1 diabetes.
Microvasc Res
; 117: 10-15, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203235
15.
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Diabetes Obes Metab
; 20(2): 427-437, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834075
16.
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes Obes Metab
; 20(2): 389-399, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28817227
17.
Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals.
Microcirculation
; 20(8): 703-16, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692260
18.
Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.
Cardiovasc Diabetol
; 11: 156, 2012 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270560
19.
Impact of micro- and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study.
Endocrinol Diabetes Metab
; 5(2): e00321, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029066
20.
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study.
Diabetes Res Clin Pract
; 185: 109218, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114299